Hitting the ground running, for ground breaking research
A rash run!
Sarah Dudgeon will be spurred on by the memory of her grandfather, whilst she runs the FLORA London Marathon 2005, and the charity responsible for funding his pioneering work on the rubella vaccine - Action Medical Research. It was back in 1968 that Action Medical Research provided vital funds for Alastair Dudgeon’s ground-breaking research. This successfully demonstrated that the rubella vaccine virus did not pass from person to person, gave long lasting immunity and was safe. Action Medical Research has been making medical breakthroughs for over 50 years, since the early days of the charity.
Sarah will be raising funds through sponsorship to help sustain this vital research, as the organisation is solely dependent on voluntary support. “I’m running in memory of my grandfather and to help raise money for similar important breakthroughs. It motivates me to keep up my training and finish the course on the day!” Sarah is a second-time London marathon runner, and works as a civil servant at the Department of Transport. When she’s not moving bills through parliament, she’s running around it! *"I'm currently working on a Bill going through Parliament, so I have to be disciplined fitting in my training with hard work and long hours. I enjoy running along the river admiring the Houses of Parliament, which look stunning in all weathers, and knowing that later on I'll be walking at a slower pace inside!"* Action Medical Research have a total of 86 runners on their team, including London marathon favourite Paddington Bear.
Alison Blower; PR Officer; Tel: 01403 327404; Email: email@example.com
Touching Tiny Lives is Action Medical Research’s new campaign to give the most vulnerable babies in this country a better start in life. More research is needed to ensure that all babies, especially babies born prematurely, grow up healthy. Touching Tiny Lives aims to raise £3 million to help fund a range of vital research. www.action.org.uk/ttl **Rubella Vaccine** The rubella (German Measles) vaccine provides immunity against rubella and is given routinely to children. Rubella is a viral infection, which mainly infects children causing a mild illness and normally gives no cause for concern.
However, eradicating rubella has been a focus of much Action Medical Research funded work in the past. This is because if a woman becomes infected with the virus during the first four months of pregnancy, it passes to the developing baby and can cause severe birth defects such as deafness, blindness, congenital heart defects and cerebral palsy. Action Medical Research's involvement with rubella research dates right back to the very first years of the Charity. The work culminated with the testing of the rubella vaccine in the late 1960's which successfully demonstrated that the vaccine virus did not pass from person to person, gave long-lasting immunity, and was safe.